Camad, Saria A.
HRN: 09-85-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/20/2024
06/27/2024
IV
500MG
Q8HR
AMOEBIASIS
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes